0001654954-22-002652.txt : 20220307 0001654954-22-002652.hdr.sgml : 20220307 20220307194013 ACCESSION NUMBER: 0001654954-22-002652 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220228 FILED AS OF DATE: 20220307 DATE AS OF CHANGE: 20220307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NIFFENEGGER KATHI CENTRAL INDEX KEY: 0001620146 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37619 FILM NUMBER: 22719922 MAIL ADDRESS: STREET 1: C/O STELLAR BIOTECHNOLOGIES, INC. STREET 2: 332 EAST SCOTT STREET CITY: PORT HUENEME STATE: CA ZIP: 93041 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edesa Biotech, Inc. CENTRAL INDEX KEY: 0001540159 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 BUSINESS PHONE: (905) 475-1234 MAIL ADDRESS: STREET 1: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 FORMER COMPANY: FORMER CONFORMED NAME: Stellar Biotechnologies, Inc. DATE OF NAME CHANGE: 20120120 4 1 section16.xml FORM 4 X0306 4 2022-02-28 0001540159 Edesa Biotech, Inc. EDSA 0001620146 NIFFENEGGER KATHI C/O EDESA BIOTECH, INC. 100 SPY COURT MARKHAM A6 L3R 5H6 ONTARIO, CANADA true Chief Financial Officer Stock Option (right to buy) 3.71 2022-02-28 4 A false 43500 0 A 2032-02-28 Common Shares 43500 43500 D This option vests monthly in equal proportions over 36 months beginning on the Grant Date. /s/ Kathi Niffenegger 2022-03-07